☆ 4.7 Editorial Material

An improved protocol for the treatment of fulminant myocarditis

SCIENCE CHINA-LIFE SCIENCES (2019)

期刊

SCIENCE CHINA-LIFE SCIENCES

卷 62, 期 3, 页码 433-434

出版社

SCIENCE PRESS

DOI: 10.1007/s11427-019-9507-x

关键词

-

类别

Biology

资金

Division of Intramural Research, National Institute of Environmental Health Sciences, NIH [Z01 ES025034]

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Medicine, General & Internal

Nursing effect of ECMO combined with CRRT in the treatment of fulminant myocarditis A protocol of randomized controlled trial

Juan Wu, Hui Zhang, Yongxia Gao, Xihua Huang

Summary: This study aims to evaluate the nursing effect and long-term efficacy and safety of ECMO combined with CRRT in the treatment of fulminant myocarditis. The results will provide clinical evidence for the treatment of fulminant myocarditis with ECMO and CRRT.

MEDICINE (2021)

添加到收藏夹

Article Pediatrics

Case report: VA-ECMO for fulminant myocarditis in an infant with acute COVID-19

Hao-Ting Hsu, Ni-Chun Kuo, Po-Yen Chen, Sheng-Ling Jan

Summary: This study presents a rare case of fulminant myocarditis in a previously healthy infant with coronavirus disease 2019. The infant rapidly deteriorated into cardiogenic shock and developed severe heart failure and multiple organ dysfunction syndrome. However, prompt treatment with central venoarterial extracorporeal membrane oxygenation and continuous venovenous hemofiltration resulted in a good recovery without significant morbidity.

FRONTIERS IN PEDIATRICS (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation

Koshiro Kanaoka, Kenji Onoue, Satoshi Terasaki, Tomoya Nakano, Michikazu Nakai, Yoko Sumita, Kinta Hatakeyama, Fumio Terasaki, Rika Kawakami, Yoshitaka Iwanaga, Yoshihiro Miyamoto, Yoshihiko Saito

Summary: The study found that patients with fulminant myocarditis presentation are at higher risk of death or heart transplantation within 90 days. Factors associated with poorer prognosis include older age, non-sinus rhythm, low left ventricular wall motion, and ventricular tachycardia or fibrillation upon admission.

CIRCULATION (2022)

添加到收藏夹

Article Medicine, General & Internal

Extracorporeal Membrane Oxygenation for Fulminant Myocarditis: Increase of Cardiac Enzyme and SOFA Score Is Associated with High Mortality

Yun Im Lee, Suryeun Chung, Ji-Hyuk Yang, Kiick Sung, Darae Kim, Jin-Oh Choi, Eun-Seok Jeon, Jeong Hoon Yang, Yang Hyun Cho

Summary: The study aimed to evaluate the outcomes of patients with fulminant myocarditis and investigate factors associated with mortality, finding that ECMO can be an effective treatment option, with CK-MB and SOFA score being significant risk factors for in-hospital mortality.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Plasma Siglec-5 and CD163 as Novel Biomarkers for Fulminant Myocarditis

Yan Zhuang, Jin Wang, Huihui Li, Yanghui Chen, Chen Chen, Dao Wen Wang

Summary: The study identified plasma Siglec-5 and CD163 as valuable novel biomarkers for the early diagnosis of fulminant myocarditis (FM).

BIOMEDICINES (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Fulminant Giant Cell Myocarditis vs. Lymphocytic Myocarditis: A Comparison of Their Clinical Characteristics, Treatments, and Outcomes

Yuxiao Hu, Jie Ren, Xueqi Dong, Di Zhang, Yi Qu, Chunxue Yang, Yang Sun, Jinghui Li, Fang Luo, Wei Wang, Huanhuan Wang, Ping Qing, Shihua Zhao, Jie Huang, Litian Yu, Yaxin Liu, Huiqiong Tan

Summary: This study compared the clinical characteristics, treatments, and outcomes in patients with fulminant giant cell myocarditis (FGCM) and fulminant lymphocytic myocarditis (FLM). The results showed that patients with FGCM had milder inflammatory responses and myocardial damage compared to those with FLM, but had poorer prognoses. hs-CRP levels could serve as a promising prognostic biomarker and an appropriate cutoff point for differentiating between FGCM and FLM patients.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

添加到收藏夹

Article Peripheral Vascular Disease

The use of extracorporeal membrane oxygenation in the treatment of fulminant myocarditis: Current progress and clinical outcomes

Xiaohong Zhang, SongLiang Wang, Jing Jia, Wen Li, Jun Li

Summary: Myocarditis is an inflammatory condition of the myocardium categorized as acute nonfulminant and acute fulminant myocarditis. ECMO is an effective technique for patients with fulminant myocarditis, providing heart and lung support to sustain life. This report reviews recent advances in ECMO and includes case studies of patients with fulminant myocarditis, discussing types of ECMO, predictive factors for success, clinical studies, and recent technological advancements in the field.

MICROVASCULAR RESEARCH (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Fulminant Myocarditis Following SARS-CoV-2 Infection JACC Patient Care Pathways

Saurabh Rajpal, Rami Kahwash, Matthew S. Tong, Kelly Paschke, Anjali A. Satoskar, Beth Foreman, Larry A. Allen, Nicole M. Bhave, Ty J. Gluckman, Valentin Fuster

Summary: A 60-year-old woman with a history of asthma developed fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. She had a complicated hospital course but ultimately recovered and was discharged with normal left ventricular systolic function. However, she later developed symptomatic ventricular tachycardia and received treatment with an implantable cardioverter-defibrillator and antiarrhythmic drugs.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Fulminant myocarditis proven by early biopsy and outcomes

Florent Huang, Enrico Ammirati, Maharajah Ponnaiah, Santiago Montero, Victor Raimbault, Darryl Abrams, Guillaume Lebreton, Vincent Pellegrino, Joshua Ihle, Maurizio Bottiroli, Romain Persichini, Marisa Isabel Barrionuevo-Sanchez, Albert Ariza-Sole, Pauline Yeung Ng, Simon Wai Ching Sin, Raj Ayer, Hergen Buscher, Slimane Belaid, Clement Delmas, Rita Ferreira, Roberto Roncon Albuquerque Jr, Teresa Lopez-Sobrino, Jeroen J. H. Bunge, Christoph Fisser, Guillaume Franchineau, Jamie Mccanny, Shinichiro Ohshimo, Alessandro Sionis, Francisco Jose Hernandez-Perez, Eduardo Barge-Caballero, Martin Balik, Henrique Muglia, Sunghoon Park, Dirk W. Donker, Beatriz Porral, Nadia Aissaoui, Armand Mekontso Dessap, Virginia Burgos, Mathieu Lesouhaitier, Justin Fried, Jae-Seung Jung, Sandra Rosillo, Vincent Scherrer, Saad Nseir, Hadrien Winszewski, Pablo Jorge-Perez, Antoine Kimmoun, Rodrigo Diaz, Alain Combes, Matthieu Schmidt, FULLMOON Study Grp

Summary: This study aimed to investigate the clinical impact of the timing of endomyocardial biopsy (EMB) in adult patients with fulminant myocarditis. The results showed that early EMB was associated with a higher survival rate free of heart transplantation or left ventricular assist device at 1 year, highlighting its potential to improve patient prognosis.

EUROPEAN HEART JOURNAL (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Clinical and Economic Evaluation of Impella Treatment for Fulminant Myocarditis-A Preliminary Retrospective Cohort Study in Japan

Tomoyuki Takura, Minoru Ono, Junya Ako, Yuji Ikari, Koichi Toda, Yoshiki Sawa

Summary: This retrospective cohort study compared the cost-effectiveness of Impella treatment with existing treatments for fulminant myocarditis. The results showed that Impella treatment had higher total costs and cost-effectiveness, and also demonstrated better 1-year survival rates and life-years compared to conventional treatments.

CIRCULATION JOURNAL (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Fulminant myocarditis caused by immune checkpoint inhibitor: a case report and possible treatment inspiration

Zhijie Liu, Yiming Fan, Jun Guo, Ning Bian, Dongdong Chen

Summary: Immune checkpoint inhibitors (ICIs) have become a new hope for advanced cancer patients by blocking tumor immune evasion. However, their use has led to an increase in immune-related adverse events (irAEs), with immune-related myocarditis being the most dangerous one. This case report highlights a successful treatment of fulminant myocarditis induced by ICIs, suggesting a potential treatment option for ICIs-associated myocarditis and improved prognosis for cancer patients.

ESC HEART FAILURE (2022)

添加到收藏夹

Article Medicine, General & Internal

Optimising the ECMO treatment regimen increases the survival rate for adult patients with acute fulminant myocarditis: A single-centre retrospective cohort study

Liusheng Hou, Hongkai Liang, Shiyong Zeng, Jianwei Li, Zhou Chen, Xiaozu Liao, Shaozhong Liu, Mingxing Li, Binfei Li, Yong Yuan

Summary: This study investigates the reasons for the improved survival rate of adult patients with acute fulminant myocarditis (AFM) after optimizing the treatment protocols. The findings suggest that early initiation of low-flow ECMO can reduce complications and improve outcomes.

FRONTIERS IN MEDICINE (2023)

添加到收藏夹

Article Infectious Diseases

Fatal fulminant HSV-2 myocarditis: A complicated presentation

Daniele Colombo, Marco Albore, Franca Del Nonno, Giorgio Bolino, Mario D'Ambrosio, Alessandra Salvi, Camilla Cecannecchia, Laura Falasca

Summary: This report presents a fatal case of fulminant myocarditis and terminal liver involvement caused by HSV-2 infection, with a unique presentation.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Soluble ST2 Is a Sensitive and Specific Biomarker for Fulminant Myocarditis

Jin Wang, Mengying He, Huihui Li, Yanghui Chen, Xiang Nie, Yuanyuan Cai, Rong Xie, Lijuan Li, Peng Chen, Yang Sun, Chenze Li, Ting Yu, Houjuan Zuo, Guanglin Cui, Kun Miao, Chunxia Zhao, Jiangang Jiang, Bettina Heidecker, Olga Barnett, Alan Maisel, Chen Chen, Dao Wen Wang

Summary: This study aimed to identify biomarkers for early diagnosis and treatment of fulminant myocarditis (FM) in order to reduce mortality. The results showed that soluble ST2 (sST2) levels in plasma could differentiate FM from non-FM or other FM-unrelated acute heart failure more robustly than other markers. Elevated sST2 level was associated with mechanical stress or inflammation and could be used as a potential biomarker for the rapid diagnosis of FM.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

添加到收藏夹

Article Immunology

Case Report: Simultaneous Hyperprogression and Fulminant Myocarditis in a Patient With Advanced Melanoma Following Treatment With Immune Checkpoint Inhibitor Therapy

Whitney Barham, Ruifeng Guo, Sean S. Park, Joerg Herrmann, Haidong Dong, Yiyi Yan

Summary: This case demonstrates that the mere presence of tumor infiltrating lymphocytes (TILs) does not necessarily correlate to ICI response, and additional functional markers are required to differentiate between inflammatory and cytolytic CD8(+) TILs. It suggests that heightened pro-inflammatory T cell activity induced by anti-PD-1 and anti-CTLA-4 may lead to rapid tumor resistance mechanisms and myocarditis.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Environmental Sciences

Association of urinary levels of bisphenols F and S used as bisphenol A substitutes with asthma and hay fever outcomes

Angelico Mendy, Paivi M. Salo, Jesse Wilkerson, Lydia Feinstein, Kelly K. Ferguson, Michael B. Fessler, Peter S. Thorne, Darryl C. Zeldin

ENVIRONMENTAL RESEARCH (2020)

添加到收藏夹

Article Immunology

Transethnic associations among immune-mediated diseases and single-nucleotide polymorphisms of the aryl hydrocarbon response gene ARNT and the PTPN22 immune regulatory gene

Shepherd H. Schurman, Terrance P. O'Hanlon, John A. McGrath, Artiom Gruzdev, Arsun Bektas, Hong Xu, Stavros Garantziotis, Darryl C. Zeldin, Frederick W. Miller

JOURNAL OF AUTOIMMUNITY (2020)

添加到收藏夹

Article Hematology

Identification of a homozygous recessive variant in PTGS1 resulting in a congenital aspirin-like defect in platelet function

Melissa Chan, Melissa A. Hayman, Suthesh Sivapalaratnam, Marilena Crescente, Harriet E. Allan, Matthew L. Edin, Darryl C. Zeldin, Ginger L. Milne, Jonathan Stephens, Daniel Greene, Moghees Hanif, Valerie B. O'Donnell, Liang Dong, Michael G. Malkowski, Claire Lentaigne, Katherine Wedderburn, Matthew Stubbs, Kate Downes, Willem H. Ouwehand, Ernest Turro, Daniel P. Hart, Kathleen Freson, Michael A. Laffan, Timothy D. Warner

Summary: This study identified a rare PTGS1 variant associated with a bleeding phenotype and alterations in platelet reactivity and eicosanoid production in a large consanguineous family. The specific loss of platelet COX-1 activity was demonstrated for the first time in humans, providing important insights into platelet function and eicosanoid metabolism. Despite the absence of thromboxane A(2) formation by platelets, urinary thromboxane A(2) metabolites were in the normal range, suggesting the need for caution when using them as markers of in vivo platelet function.

HAEMATOLOGICA (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Profiling the eicosanoid networks that underlie the anti- and pro-thrombotic effects of aspirin

Marilena Crescente, Paul C. Armstrong, Nicholas S. Kirkby, Matthew L. Edin, Melissa Chan, Fred B. Lih, Jing Jiao, Tania Maffucci, Harriet E. Allan, Charles A. Mein, Carles Gaston-Massuet, Graeme S. Cottrell, Jillian A. Mitchell, Darryl C. Zeldin, Harvey R. Herschman, Timothy D. Warner

FASEB JOURNAL (2020)

添加到收藏夹

Letter Hematology

A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect on platelet function and bleeding diathesis

Veronica Palma-Barqueros, Marilena Crescente, Maria Eugenia de la Morena, Melissa V. Chan, Elena Almarza, Nuria Revilla, Natalia Bohdan, Antonia Minano, Jose Padilla, Harriet E. Allan, Tania Maffucci, Matthew L. Edin, Darryl C. Zeldin, Cristina Mesa-Nunez, Carlos Damian, Ana Marin-Quilez, Rocio Benito, Irene Martinez-Martinez, Nuria Bermejo, Ignacio Casas-Aviles, Agustin Rodriguez-Alen, Jose R. Gonzalez-Porras, Jesus Maria Hernandez-Rivas, Vicente Vicente, Javier Corral, Maria L. Lozano, Timothy D. Warner, Jose Maria Bastida, Jose Rivera

AMERICAN JOURNAL OF HEMATOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Soluble epoxide hydrolase deficiency attenuates lipotoxic cardiomyopathy via upregulation of AMPK-mTORC mediated autophagy

Luyun Wang, Daqiang Zhao, Liangqiu Tang, Huihui Li, Zhaoyu Liu, Jingwei Gao, Matthew L. Edin, Huanji Zhang, Kun Zhang, Jie Chen, Xinhong Zhu, Daowen Wang, Darryl C. Zeldin, Bruce D. Hammock, Jingfeng Wang, Hui Huang

Summary: sEH deficiency plays a crucial role in attenuating cardiac lipid accumulation and dysfunction, which is associated with the regulation of autophagy via the AMPK-mTORC signaling pathway.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Soluble Epoxide Hydrolase in Aged Female Mice and Human Explanted Hearts Following Ischemic Injury

K. Lockhart Jamieson, Ahmed M. Darwesh, Deanna K. Sosnowski, Hao Zhang, Saumya Shah, Pavel Zhabyeyev, Jun Yang, Bruce D. Hammock, Matthew L. Edin, Darryl C. Zeldin, Gavin Y. Oudit, Zamaneh Kassiri, John M. Seubert

Summary: Myocardial infarction (MI) is a significant cause of death in aged individuals, with females experiencing increased risk during the peri-menopausal period. Research shows that sEH levels are elevated in ischemic LV specimens, impacting oxylipid metabolism and mitochondrial enzymatic function. Targeting sEH with inhibitors or genetic deletion improves survival and cardiac function in female mice following MI.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Hematology

Proteome and functional decline as platelets age in the circulation

Harriet E. Allan, Melissa A. Hayman, Simone Marcone, Melissa Chan, Matthew L. Edin, Tania Maffucci, Abhishek Joshi, Laura Menke, Marilena Crescente, Manuel Mayr, Darryl C. Zeldin, Paul C. Armstrong, Timothy D. Warner

Summary: Our study reveals that changes in protein content are associated with alterations in platelet structure and function as they age. Analysis suggests higher hemostasis in young platelets and increased apoptosis and senescence in old platelets. In-depth investigation shows reduced cytoskeletal protein, fewer mitochondria, and decreased calcium dynamics and granule secretion in aged platelets.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Review Nutrition & Dietetics

Natural Products in the Prevention of Metabolic Diseases: Lessons Learned from the 20th KAST Frontier Scientists Workshop

Seung J. Baek, Bruce D. Hammock, In-Koo Hwang, Qingxiao Li, Naima Moustaid-Moussa, Yeonhwa Park, Stephen Safe, Nanjoo Suh, Sun-Shin Yi, Darryl C. Zeldin, Qixin Zhong, Jennifer Alyce Bradbury, Matthew L. Edin, Joan P. Graves, Hyo-Young Jung, Young-Hyun Jung, Mi-Bo Kim, Woosuk Kim, Jaehak Lee, Hong Li, Jong-Seok Moon, Ik-Dong Yoo, Yiren Yue, Ji-Young Lee, Ho-Jae Han

Summary: In the 21st century, the incidence of metabolic and chronic diseases, such as cancer, obesity, and inflammation-related diseases, has sharply increased, with inflammation and oxidative stress being major underlying causes. Natural products and their bioactive components are increasingly recognized as promising therapeutic agents for these diseases due to their antioxidant and anti-inflammatory properties. Research in this area has expanded significantly to include chemical identification, mechanism of action determination, food fortification, supplement development, and enhancing bioavailability and bioactivity through nanotechnology.

NUTRIENTS (2021)

添加到收藏夹

Article Respiratory System

Serum antioxidant vitamins and respiratory morbidity and mortality: a pooled analysis

Paivi M. Salo, Angelico Mendy, Jesse Wilkerson, Samantha A. Molsberry, Lydia Feinstein, Stephanie J. London, Michael B. Fessler, Peter S. Thorne, Darryl C. Zeldin

Summary: In this study, lower serum levels of vitamins A, C, D, and E were found to be associated with increased respiratory morbidity and/or mortality in the U.S. adult population. These results underscore the importance of antioxidant vitamins in respiratory health.

RESPIRATORY RESEARCH (2022)

添加到收藏夹

Article Medicine, Research & Experimental

sEH promotes macrophage phagocytosis and lung clearance of Streptococcus pneumoniae

Hong Li, J. Alyce Bradbury, Matthew L. Edin, Joan P. Graves, Artiom Gruzdev, Jennifer Cheng, Samantha L. Hoopes, Laura M. DeGraff, Michael B. Fessler, Stavros Garantziotis, Shepherd H. Schurman, Darryl C. Zeldin

Summary: EETs have been shown to reduce macrophage activation and phagocytosis of Streptococcus pneumoniae by downregulating TLR2 and PGLYRP1 expression. Ephx2(-/-) mice had impaired lung bacterial clearance and reduced phagocytosis by macrophages.

JOURNAL OF CLINICAL INVESTIGATION (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Epoxide hydrolase 3 (Ephx3) gene disruption reduces ceramide linoleate epoxide hydrolysis and impairs skin barrier function

Matthew L. Edin, Haruto Yamanashi, William E. Boeglin, Joan P. Graves, Laura M. DeGraff, Fred B. Lih, Darryl C. Zeldin, Alan R. Brash

Summary: The mammalian epoxide hydrolase (EPHX)3 is responsible for hydrolyzing epoxyalcohol derived triols in the 12R-lipoxygenase pathway and plays a crucial role in maintaining skin barrier integrity. This enzyme is essential for controlling metabolism flux through the alternative pathway and contributes to the transformation of naturally esterified epoxide substrates in other tissues.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

添加到收藏夹

Review Toxicology

Regulation of cardiovascular biology by microsomal epoxide hydrolase

Matthew L. Edin, Darryl C. Zeldin

Summary: Microsomal epoxide hydrolase (mEH) plays a crucial role in metabolizing compounds such as xenobiotics and pharmaceuticals by converting hydrophobic epoxides to hydrophilic diols. While mEH has been less studied in endogenous epoxy-fatty acid (EpFA) metabolism, recent findings suggest it may have a substantial impact on cardiovascular function through regulation of EpFA metabolism, particularly in the metabolism of epoxyeicosatrienoic acid (EET). Further research on the role of mEH in cardiovascular biology is warranted.

TOXICOLOGICAL RESEARCH (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities

James Jiqi Wang, Matthew L. Edin, Darryl C. Zeldin, Chenze Li, Dao Wen Wang, Chen Chen

PHARMACOLOGY & THERAPEUTICS (2020)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.